Spoken Alpha
DGX
QUEST DIAGNOSTICS INC
Overview
Quest Diagnostics provides clinical laboratory testing and diagnostic information services to physicians, hospitals, patients, and consumers across the United States.
QUEST DIAGNOSTICS INC is a Healthcare company operating in Diagnostics & Research with a $27.20B market cap.
Most recent reported earnings: Q3 FY2026 (Oct 19, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-08-30.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q2 FY2026Earnings2026-07-2315 Q&A exchanges
- Q1 FY2026Earnings2026-04-2114 Q&A exchanges
- Q4 FY2025Earnings2026-02-1017 Q&A exchanges
- Q3 FY2025Earnings2025-10-2114 Q&A exchanges
- Q2 FY2025Earnings2025-07-2216 Q&A exchanges
- Q1 FY2025Earnings2025-04-2217 Q&A exchanges
- Q4 FY2024Earnings2025-01-3013 Q&A exchanges
- Q3 FY2024Earnings2024-10-2217 Q&A exchanges
- Q2 FY2024Earnings2024-07-2315 Q&A exchanges
- Q1 FY2024Earnings2024-04-2320 Q&A exchanges
- Q4 FY2023Earnings2024-02-0113 Q&A exchanges
- Q3 FY2023Earnings2023-10-2415 Q&A exchanges
- Q2 FY2023Earnings2023-07-2613 Q&A exchanges
- Q1 FY2023Earnings2023-04-2714 Q&A exchanges
- Q4 FY2022Earnings2023-02-0226 Q&A exchanges
- Q3 FY2022Earnings2022-10-2016 Q&A exchanges
- Q2 FY2022Earnings2022-07-2113 Q&A exchanges
- Q1 FY2022Earnings2022-04-2122 Q&A exchanges
- Q4 FY2021Earnings2022-02-0325 Q&A exchanges
- Q3 FY2021Earnings2021-10-2118 Q&A exchanges
- Q2 FY2021Earnings2021-07-2215 Q&A exchanges
- Q1 FY2021Earnings2021-04-2216 Q&A exchanges
History
Earnings history
- Q3 FY20262026-10-19EPS— vs $2.85—Rev— vs ——EODHD
- Q2 FY20262026-07-22EPS$3.12 vs $2.81+11.0%Rev$3.04B vs ——EODHD
- Q1 FY20262026-04-20EPS$2.50 vs $2.37+5.5%Rev$2.90B vs ——EODHD
- Q4 FY20252026-02-09EPS$2.42 vs $2.36+2.5%Rev$2.81B vs ——EODHD
- Q3 FY20252025-10-20EPS$2.60 vs $2.50+4.0%Rev$2.82B vs ——EODHD
- Q2 FY20252025-07-21EPS$2.62 vs $2.57+1.9%Rev$2.76B vs ——EODHD
- Q1 FY20252025-04-21EPS$2.21 vs $2.15+2.8%Rev$2.65B vs ——EODHD
- Q4 FY20242025-01-29EPS$2.23 vs $2.18+2.3%Rev$2.62B vs ——EODHD
- Q3 FY20242024-10-21EPS$2.30 vs $2.26+1.8%Rev$2.49B vs ——EODHD
- Q2 FY20242024-07-22EPS$2.35 vs $2.33+0.9%Rev$2.40B vs ——EODHD
- Q1 FY20242024-04-22EPS$2.04 vs $1.86+9.7%Rev$2.37B vs ——EODHD
- Q4 FY20232024-01-31EPS$2.15 vs $2.11+1.9%Rev$2.29B vs ——EODHD
- Q3 FY20232023-10-23EPS$2.22 vs $2.19+1.4%Rev$2.29B vs ——EODHD
- Q2 FY20232023-07-25EPS$2.30 vs $2.26+1.8%Rev$2.34B vs ——EODHD
- Q1 FY20232023-04-26EPS$2.04 vs $1.97+3.5%Rev$2.33B vs ——EODHD
- Q4 FY20222023-02-01EPS$1.98 vs $1.90+4.2%Rev$2.33B vs ——EODHD
- Q3 FY20222022-10-19EPS$2.36 vs $2.19+7.8%Rev$2.49B vs ——EODHD
- Q2 FY20222022-07-20EPS$2.36 vs $2.27+4.0%Rev$2.45B vs ——EODHD
- Q1 FY20222022-04-20EPS$3.22 vs $3.00+7.3%Rev$2.61B vs ——EODHD
- Q4 FY20212022-02-02EPS$3.33 vs $3.21+3.7%Rev$2.74B vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-19 | — | $2.85 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-07-22 | $3.12 | $2.81 | +11.0% | $3.04B | — | — | EODHD |
| Q1 FY2026 | 2026-04-20 | $2.50 | $2.37 | +5.5% | $2.90B | — | — | EODHD |
| Q4 FY2025 | 2026-02-09 | $2.42 | $2.36 | +2.5% | $2.81B | — | — | EODHD |
| Q3 FY2025 | 2025-10-20 | $2.60 | $2.50 | +4.0% | $2.82B | — | — | EODHD |
| Q2 FY2025 | 2025-07-21 | $2.62 | $2.57 | +1.9% | $2.76B | — | — | EODHD |
| Q1 FY2025 | 2025-04-21 | $2.21 | $2.15 | +2.8% | $2.65B | — | — | EODHD |
| Q4 FY2024 | 2025-01-29 | $2.23 | $2.18 | +2.3% | $2.62B | — | — | EODHD |
| Q3 FY2024 | 2024-10-21 | $2.30 | $2.26 | +1.8% | $2.49B | — | — | EODHD |
| Q2 FY2024 | 2024-07-22 | $2.35 | $2.33 | +0.9% | $2.40B | — | — | EODHD |
| Q1 FY2024 | 2024-04-22 | $2.04 | $1.86 | +9.7% | $2.37B | — | — | EODHD |
| Q4 FY2023 | 2024-01-31 | $2.15 | $2.11 | +1.9% | $2.29B | — | — | EODHD |
| Q3 FY2023 | 2023-10-23 | $2.22 | $2.19 | +1.4% | $2.29B | — | — | EODHD |
| Q2 FY2023 | 2023-07-25 | $2.30 | $2.26 | +1.8% | $2.34B | — | — | EODHD |
| Q1 FY2023 | 2023-04-26 | $2.04 | $1.97 | +3.5% | $2.33B | — | — | EODHD |
| Q4 FY2022 | 2023-02-01 | $1.98 | $1.90 | +4.2% | $2.33B | — | — | EODHD |
| Q3 FY2022 | 2022-10-19 | $2.36 | $2.19 | +7.8% | $2.49B | — | — | EODHD |
| Q2 FY2022 | 2022-07-20 | $2.36 | $2.27 | +4.0% | $2.45B | — | — | EODHD |
| Q1 FY2022 | 2022-04-20 | $3.22 | $3.00 | +7.3% | $2.61B | — | — | EODHD |
| Q4 FY2021 | 2022-02-02 | $3.33 | $3.21 | +3.7% | $2.74B | — | — | EODHD |
Source: EODHD. DGX reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- J E DavisCEO3 yr 10 mono recorded callsCurrent
- Sam SamadCFO4 yr 2 mo17 callsCurrent
- Mark E DelaneySVP & Chief Commercial Officer3 yr 10 mono recorded callsCurrent
- Catherine T DohertyEVP, Regional Businesses2 yr 7 mono recorded callsCurrent
- Michael J DeppeSVP, Corp. Controller & CAO3 yr 7 mono recorded callsCurrent
- Karthik KuppusamySVP, Clinical Solutions3 yr 10 mono recorded callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for DGX.
$ curl https://api.spokenalpha.com/v1/companies/DGXFAQ
Frequently asked about DGX
Where can I find QUEST DIAGNOSTICS INC's (DGX) earnings call transcripts?
Spoken Alpha indexes DGX's earnings call transcripts at https://spokenalpha.com/companies/DGX. Each call links to attributed speakers and parsed analyst Q&A. QUEST DIAGNOSTICS INC's own investor relations page is at https://ir.questdiagnostics.com/overview/default.aspx.
When was QUEST DIAGNOSTICS INC's most recent earnings call?
QUEST DIAGNOSTICS INC (DGX) held its most recent earnings call on 2026-07-23, covering fiscal Q2 2026.
What sector is DGX in?
QUEST DIAGNOSTICS INC (DGX) operates in the Healthcare sector (Diagnostics & Research industry).